Teduglutide, a Novel Analogue of Glucagon-like Peptide 2 (GLP-2), Is Effective and Safe in Reducing Parenteral Support Volume in Short Bowel Syndrome–Intestinal Failure Subjects: Results From a 24-Week, Placebo-Controlled Phase 3 Trial (STEPS)

✍ Scribed by Palle B. Jeppesen; Marek Pertkiewicz; Douglas L. Seidner; Stephen O'Keefe; Hartmut Heinze; Bo Joelsson

• Book ID: 119432440
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 192 KB
• Volume: 140
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(11)60593-3